chrisvoncsefalvay/vaers-outcomes huggingface dataset:
feel kind of little bit of pain in my heart, I feel like in my lung; feel kind of little bit of pain in my heart, I feel like in my lung; got huge swelling under my neck on the left side/ swelling in the back; some pain in my chest; left arm has got kind of also very numb I cannot hold stuff with my left arm; Fever; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number and expiration date unknown) via an unspecified route of administration at left arm on 07Apr2021 (unknown age at time of vaccination), at single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient stated, "I took second shot of Pfizer vaccine COVID 19, for COVID it was almost 07Apr2021 and right after that a period later I got huge swelling under my neck on the left side and I took the vaccine on the left arm also and then I had huge fever also for basically 24 hours and recently I have been experiencing swelling in the back and also some pain in my chest and today my left arm has got kind of also very numb I cannot hold stuff with my left arm and sometimes I also feel kind of little bit of pain in my heart, I feel like in my lung. So, I don't know whom I should go visit to show me. Do these symptoms make sense is it dangerous or not?" The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Patient presented to the hospital with worsening cough and weakness, patient tested positive for covid a week PTA, patient currently on immunosuppressive therapy for renal transplant. Patient diagnosed with Covid-19 pneumonia. Patient received Remdesivir and IV steroids, IV abx. Patient passed his walk study and did not need home oxygen.
COPD exacerbation; SOB (shortness of breath); Shortness of breath; Suspected COVID-19 virus infection
Diagnosed with Crohn's disease 1999. Was asymptomatic 24 hrs after vaccination. Shortly thereafter had muscle ache and fever. 48hrs later, adominal pain with blood. Later symptoms continued with fatigue. 7 days later started Entoent. symptoms started 24hrs later. Rx prescrbed by doctor.
Her period came one week earlier than planned. It's was more painful and heavier.; Her period came one week earlier than planned. It's was more painful and heavier.; Her period came one week earlier than planned. It's was more painful and heavier.; Chills; Sore throat; This is a spontaneous report from a contactable nurse (patient).  A 45-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: EJ1685), via an unspecified route of administration on 21Dec2020 at SINGLE DOSE for COVID-19 immunization.  Medical history included ongoing chronic migraines.  Concomitant medications included ascorbic acid (VIT C), and ergocalciferol (VIT D). On 21Dec2020, the patient received the vaccine. After 48 hours (23Dec2020), she had chills, and a sore throat but no fever. It was mentioned that the chills and sore throat just lasted for one day. On 03Jan2021, the patient mentioned that her period came one week earlier than planned. It's was more painful and heavier. She mentioned that she always had a difficult period, but this this one seems more intensified (10 times) and was very painful. It was mentioned that the patient was getting the second one next week. The patient recovered from chills and sore throat on 24Dec2020 while not recovered for the remaining events
Several minutes after administration, became tachycardia with HR in the 160s, diffusely erythematous, short of breath and dizzy with sense of impending doom.   Resolved after about 5 minutes.  No epi needed.
Case number PHEH2016US023361, is an initial spontaneous report received from a nurse on 13 Sep 2016. This report refers to a 53 years old patient of unknown gender. Past medical history and concomitant medications were not reported. The patient was vaccinated with one single dose of FLUVIRIN (batch number: 1515701) at a dose of 0.5 ml, intramuscularly, into right arm on 01 Dec 2015. On 01 Dec 2015, FLUVIRIN MDV  that had been exposed to 8 to 10 temperature excursions was administered to patient. No adverse event was reported following this medication error. The case was assessed as non-serious by the nurse.
RED, SWOLLEN, FEVERISH,PAINFUL, WITH FLUID FILLED BLISTERS
Two days after vaccine, I experienced bilateral breast soreness,  It felt as if I was going to have a menstrual period soon, even though I haven't had one in 25 years!  It continued for about 3 weeks.  I self-medicated with aspirin at home.  And nothing else happened.
Both arms hurting, hot, sore for 1 wk - woke up with arms stabbing in pain and stiff and numb hands. Suffered for 2 1/2 months after seeing 2 doctors with no help. The suffering was horrible. Will never forget this!!!
On 11/01/2000 the patient developed 5 or 6 papules. On approximately 11/03/2000 the patient was seen at the physician's office and had approximately two dozen lesions, slighty vesicular and some had already scabbed over. The patient had a fever and headache one day. The nurse also reported that the child's lesions were "resolving quite nicely". On 11/07/2000 the patient recovered. No further information is expected.
Within hours of the shot I had burning, dull pain in my right shoulder. This pain steadily increased in severity over the next 72 hours and my range of motion both up/down and side/side became severely limited. I went to a general urgent care on 11/29/19 to reassess possible shingles and the pain in my shoulder but was told to see if it would dissipate on its own. I then went to an orthopedic urgent care on 12/8/19 and had x-rays and was diagnosed with impingement with probable subchromial bursitis secondary to a recent flu shot, and was told to see a orthopedic MD. I had an appointment with Dr. on 12/18/19 in which she gave a cortisone shot in the right shoulder and she ordered an MRI that was performed on 12/19/19. I followed up with Dr. on 12/23 and was told the MRI showed I had mild sub-chromial bursitis and possible Parsonage Turner syndrome. Dr. ordered physical therapy and continued monitoring. Symptoms continued to persist and Dr. ordered an EMG which was performed on 1/27/20. On 2/10/20 I followed up with Dr. and was told the EMG was normal and to continue PT. On 2/24/20 symptoms continued to persist and Dr. gave a 2nd cortisone shot. Symptoms continued to persist and Dr. ordered a 2nd MRI which was performed on 4/8/20.
patient is 10 years of age. per vaccine biavalent she needs to be 12 yeaRS.
Headache-2 days Decreased appetite-2 days Body aches- 2 days Fatigue- 2 days  Redness, swelling and pain at injection site- 3 days Symptoms started on day 2. Filing this report on day 3.
She received first dose of Pfizer-BioNTech COVID-19 Vaccine on 08Mar2021/tested positive COVID-19 last week; She received first dose of Pfizer-BioNTech COVID-19 Vaccine on 08Mar2021/tested positive COVID-19 last week; This is a spontaneous report from a contactable consumer (patient herself). A 56-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, unknown lot number and expiration) via an unspecified route of administration on 08Mar2021 at SINGLE DOSE for covid-19 immunisation. The patients medical history and concomitant medications were not reported. The patient experienced she received first dose of pfizer-biontech covid-19 vaccine on 08mar2021/tested positive covid-19 last week (covid-19) in Mar2021. The reporter assessed the event as non-serious.  The patient underwent lab tests and procedures which included sars-cov-2 test: positive in Mar2021. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a medical assistant refers to patient of unknown age and gender. On 13-AUG-2014, the patient were vaccinated with GARDASIL (0.5 ml, lot#J0112725, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Fever highest 102.7, dry cough, muscle aches, migraine headaches, dizziness, confined to bed, anorexia, hypotension.
On February 18 or 19, noticed a 5 mm. purpuric skin lesion on right hand, not painful.  On about February 19, perhaps in the evening, noted varied perhaps 5 mm discolorations on ankles that in retrospect were probably resolved mild purpuric lesions.  On the same evening, noted very mild tenderness in the calf (soleus muscle) regions bilaterally feeling like mild muscle fatigue.  On February 21 at about 6 AM, before showering, noted bright cherry red lesions on/under skin of both ankles and more severely on the posterior calf of both lower legs above the calf tenderness.  The skin was flat and not tender.  Calf tenderness was slightly worse (though still mild).  Lesions turned purpuric, fading in hours.
Doses given after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses given after temperature excursion) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses given after temperature excursion). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses given after temperature excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter. No treatment medication was provided.
Information has been received from a nurse concerning a female who on 10-JUL-2009 was vaccinated SC with one dose of ZOSTAVAX (Merck) (lot # not reported) in a healthcare facility. On 22-NOV-2010 the patient experienced shingles. The outcome of shingles was unknown. Unspecified treatment was given to the patient. The patient sought unspecified medical attention. No further information is available.
Little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Little sore arm) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012H21B, 007M20A and 030A21A) for COVID-19 vaccination.     The patient's past medical history included Tracheostomy (Tracheotomy on neck.). Concurrent medical conditions included Diabetes, Blood pressure high and Lung disorder NOS. Concomitant products included VITAMIN D [VITAMIN D NOS] and VITAMIN B [VITAMIN B NOS] for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Little sore arm). At the time of the report, VACCINATION SITE PAIN (Little sore arm) had resolved.            Concomitant medications reported also included medication for sugar, medication for high blood pressure and four different inhalers for lung problems.  No treatment medication was provided.   This case was linked to MOD-2021-405078, MOD-2021-405059 (Patient Link).
From ~8 PM on 2/28/2022 to ~3 PM on 3/1/2022 - fever over 99 degrees, aches in joints, chills, headache .
I had two adverse reactions to the shot the first one was tingling at the tip of my tongue and the other one was my nose appeared to be red and it felt like it was stopped up this lasted for about 15 to twenty minutes.
This spontaneous report was received from a health care professional refers to multiple unspecified patients of unknown demographics. On multiple unspecified dates the patient were vaccinated with improperly stored GARDASIL lot # K008931; expiry: 04-MAR-2017 (dose, route and frequency unspecified). No further information was available. Additional information has been requested.
Started with itchy eyes and runny nose 4/13/21. 4/14/21 developed conjunctivitis, fever, body aches, shortness of breath and cough, fatigue. Symptoms improving.
I developed a headache the evening of my vaccine. Not prone to headaches/migraines. Reported this to my PCP who stated it's a fairly common reaction. After 9 days of increasingly worse headaches, I went to Urgent Care on 1/21/2021 and was given a toradol injection. The headache exacerbated already existing back and neck pain to an off the chart pain level. I am still experiencing left arm pain radiating to left chest and neck area.
Abnormal menstrual spotting.  My period ended the day I got the 2nd dose and I started spotting 4 days later. Am still spotting now 6 days later. This is incredibly abnormal for me and there is no way I am pregnant
Notified by (Infectious Disease Nurse) that patient received her second dose of the COVID vaccine but it was the correct COVID vaccine. Pt's first dose was Moderna on 7/9/21. Pt was given Pfizer as her second COVID vaccine on 8/5/21. No adverse event occurred to patient.
Patient woke up the morning of 10/20/21 and noticed that her middle finger on her left hand was numb.  On 10/21/21 the patient's middle and ring fingers on her left hand swelled up and were "tingly."  Patient took oral benadryl (25mg) and the swelling went down. On 10/22/21 the middle and ring fingers were numb again when the patient woke up.  Throughout the day on 10/22/21 the patient's symptoms started progressively getting better.  Now ,the patient's fingers are much better but  the patient still has the sensation of "wearing a glove" on her middle finger on left hand.
Pt. states went to ER on 2-11-11 night of injection, with SOB arm swollen & red & hot to touch. Arm swelling & even under her armpit. Had limited mobility of that arm & while at ER started breaking out in welts. ER gave her IV meds & sent her home on steroids. - This is all per pt. We also received a Triage call report from where pt had called in to them.
Tinnitis (fluttering) started a day post booster shot, 8 weeks pregnant due date may 27th, 2022.
Head ache; Moderate injection site pain; Pain when raising arm above horizontal; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 at 15:15 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 03Apr2021 at 08:00, the patient experienced headache, moderate injection site pain and pain when raising arm above horizontal. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events headache, moderate injection site pain and pain when raising arm above horizontal was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Pt reported that she received injections of LYMErix on 4/13/99, 5/13/99, and 3/9/00. On an unspecified date in 2001, pt's right knee completely failed. She was seen by MD and reportedly advised that she would need to undergo knee replacement surgery. She stated that MD did not have a reason for her knee to go completely. The pt stated that she believed that LYMErix administration caused the knee problem. This report of a failed knee is considered medically serious because the pt was reportedly advised to undergo surgery. This report of a labeled event is being submitted as an expedited report by special FDA request per the 6/28/00 letter. Follow up received on 02/04/2002 states that there was no history of gout, Crohn's disease, or Lyme disease. There was no family history of rheumatoid arthritis or lupus. Concurrent medications included paracetamol for relief of arthritic pain, beginning 01/10/2001. Vaccine provider reports that the pt began to experience acceleration of arthritic pain of the right knee in February 2001. 11 months following receipt of the third injection of LYMErix. No swollen or warm joints were observed on physican examination. No joint fluid was obtained for analysis. No diagnostic laboratory evaluation was performed by the vaccine provider. He prescribed Vioxx and referred the pt to an orthopedic surgeon. The arthopedic surgeon injected hyaluronic acid into the pt's right knee on 07/12/2001, 07/19/2001 and 07/26/2001. The vaccine provider did not confirm that the pt will undergo knee replacement surgery. The acceleration of right knee arthritic pain was ongoing. The vaccine provider considered the event to be severe, disabling and possibly related to LYMErix administration. The vaccine provider also considered the event to be possibly relate dto the pt's pre-existing arthritis. *F/UP report on 3/3/03: Medical history included "mild" (according to the PT) non-inflammatory arthritis of the right knee.*
sore arm the first day; tired for about four hours; soreness at injection site; last night/night before he can feel his heart beat in the middle of stomach/happens when he lies on his back; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (sore arm the first day), FATIGUE (tired for about four hours), VACCINATION SITE PAIN (soreness at injection site) and FEELING ABNORMAL (last night/night before he can feel his heart beat in the middle of stomach/happens when he lies on his back) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy, Allergy to antibiotic and Milk protein allergy.    On 13-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (sore arm the first day) (seriousness criterion medically significant), FATIGUE (tired for about four hours) (seriousness criterion medically significant), VACCINATION SITE PAIN (soreness at injection site) (seriousness criterion medically significant) and FEELING ABNORMAL (last night/night before he can feel his heart beat in the middle of stomach/happens when he lies on his back) (seriousness criterion medically significant). At the time of the report, MYALGIA (sore arm the first day), FATIGUE (tired for about four hours), VACCINATION SITE PAIN (soreness at injection site) and FEELING ABNORMAL (last night/night before he can feel his heart beat in the middle of stomach/happens when he lies on his back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
some of the liquid aerosolized and shot up and out; Syringe somewhat exploded; needle may not have been on all the way; A spontaneous report was received from a man concerning his wife, a female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced incorrect dose administered, syringe issue, and product administration error.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 30 Dec 2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. During the administration, the reporter stated that when the nurse pushed the needle into the patient's muscle, the syringe somewhat exploded and some of the liquid aerosolized and shot up and out. The reporter stated that the nurse and pharmacist present during vaccine administration thought the needle may not have been on all the way which caused the issue. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events, incorrect dose administered, syringe issue, and product administration error were considered resolved on 30 Dec 2020.; Reporter's Comments: This case concerns a female patient who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Incorrect dose administered, Syringe issue, and Product administration error without any associated adverse events.
Moderna Bivalent dose (given on 9/16/22) only 1 month after the last Moderna booster dose (given on 8/11/22 ) Patient was informed  of the administration error 1 hour after the shot. He is not experiencing any side effects other than sore arm.
No additional adverse effects were reported; patient, seven months of age, inadvertently received PNEUNOVAX 23, instead of PREVNAR 13; This spontaneous report was received from a medical assistant and refers to a 7-month-old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 13-JUL-2020, the patient was inadvertently vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) 0.5 ml, once, lot # S028601, expiration date 02-JUN-2021 (injection site and route of administration were not reported) for prophylaxis instead of pneumococcal 13v conj vaccine (crm197)(PREVNAR 13) (exact dose, injection site, route of administration, lot # and expiration date were not reported). No additional adverse effects were reported.
Patient was vaccinated with first dose of pfizer on 5/1/21.  During vaccination, the needle bent and leaked after 0.1 cc was injected.  Given risk of reusing a bent needle and the unknown amount of vaccine that leaked, per CDC guidelines, as the patient was given < 1/2 of the dose, he was given a 2nd dose of 0.3 Pfizer immediately with a new syringe and needle.
Redness, swelling and warmth in the upper arm where the injection was administered. The arm is also sore. Patient also experienced head and body aches starting the day after receiving the vaccine. She had a temperature of 99.3 degrees the evening after receiving the vaccine, but no fever since.
This is a spontaneous report from a non-contactable consumer via Pfizer sales representative. An adolescent patient of unspecified age and gender received TRUMENBA on an unspecified date, at single dose, for immunization. Medical history and concomitant medications were not provided. On an unspecified date they got funky side effects at the injection site but realized they needed to shake the dose vigorously and the issue resolved. Information on the batch number has been requested.
Moderna COVID-19 vaccine EUA Vomiting, chills, no appetite, headache, temperature of 99.7 lasting  2 days. Used OTC tylenol. Symptoms starting to improve on 1.15.21.